Alerts will be sent to your verified email
Verify Email
APL
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Asston Pharmaceuticals is engaged in the manufacturing and export of both pharmaceutical formulations and nutraceutical products in domestic and various African markets. The company operates under brand ‘Asston’. The company is involved in the business of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel and Lotion) and Oral Powder (Sachet, Dry Syrup) etc.
Asston Pharma major competitors are Shelter Pharma, Bafna Pharma, Trident Lifeline.
Market Cap of Asston Pharma is ₹102 Crs.
While the median market cap of its peers are ₹211 Crs.
Asston Pharma seems to be less financially stable compared to its competitors.
Altman Z score of Asston Pharma is 0 and is ranked 4 out of its 4 competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | ||||||||||||||||||
| Investor Presentation | ||||||||||||||||||
| Conference Call | ||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
